Stocks
Merck & Co.'s Stock Price Dips After Strong Run
Merck & Co.'s stock price dropped by about 1.0 percent on September 8, 2026, closing at around USD 148 on the NYSE. This decline comes after a strong run that saw the shares reach their upper end of their 52-week range.
The recent high for Merck & Co.'s stock was USD 156.92 in late August, and it had been trading near this level before the slight decrease. The stock's price is now about 4 percent below its 52-week peak.
On September 8, analyst activity provided a notable backdrop for the session. Guggenheim raised its price target on Merck from USD 146 to USD 170 while reiterating a buy rating, citing higher sales estimates for oncology assets following positive data.